News tagged with glaxosmithkline

Related topics: diabetes , heart attack , food and drug administration , vaccine

Pharma data play larger role in anti-doping effort

Some of the world's biggest drugmakers are playing a larger role in anti-doping efforts at this year's Winter Olympics: They're providing information on drugs that once would have been considered proprietary trade secrets.

Feb 07, 2014
popularity not rated yet | comments 0

GSK to scrap individual sales targets (Update)

British drug company GlaxoSmithKline said Tuesday it would stop paying doctors to promote its products at speaking engagements and scrap individual sales targets, months after its ethics were challenged by a bribery scandal ...

Dec 17, 2013
popularity not rated yet | comments 0

GSK says sells thrombosis brands, French site

British drugs firm GlaxoSmithKline (GSK) said Monday that it has sold two thrombosis brands and a French plant to South African peer Aspen for £700 million ($1.13 billion, 834 million euros).

Sep 30, 2013
popularity not rated yet | comments 0

New drug approved to treat HIV-1

(HealthDay)—Tivicay (dolutegravir) has been approved by the U.S. Food and Drug Administration to treat infection with HIV-1, a strain of the virus that causes AIDS.

Aug 13, 2013
popularity 5 / 5 (1) | comments 0

GlaxoSmithKline

GlaxoSmithKline plc (LSE: GSK NYSE: GSK) is a United Kingdom-based pharmaceutical, biological, and healthcare company. GSK is the world's second largest pharmaceutical company and a research-based company with a wide portfolio of pharmaceutical products covering anti-infectives, central nervous system, respiratory, gastro-intestinal/metabolic, oncology, and vaccines products. It also has a Consumer Healthcare operation comprising leading oral healthcare products, nutritional drinks, and over the counter medicines. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.

This text uses material from Wikipedia licensed under CC BY-SA